Plus   Neg

Althea Group Signs Medicinal Cannabis Supply Deal With UK's Grow Pharma

Althea Group Holdings said Tuesday it has entered into a medicinal cannabis supply deal with UK-based Grow Pharma to import, sell and distribute Althea products in the UK. Althea Group is an Australian licensed producer, supplier and exporter of pharmaceutical grade medicinal cannabis.

Grow Pharma, a joint venture of Grow Biotech PLC and IPS Pharma, is an independent UK distributor of cannabis-based products for medicinal use in humans or CBPMs.
Under the agreement between the two companies, Althea's full suite of medical cannabis products will be added to the Grow Pharma formulary.

Grow Pharma has agreed to a wholesale purchase price for Althea products and has also committed to not exceed the maximum retail price of Althea products in the UK.

Althea Group noted that the deal with Grow Pharma will further expand its presence in the UK by adding new prescribers, patients, and supplementary revenue.

"With approximately 90,000 specialists in the UK, the agreement with Grow Pharma provides Althea with additional channels for patient access and more prescriber coverage, accelerating the growth of our brand," said Althea CEO Joshua Fegan.

Althea Group said its growth in the UK has been supported by the ongoing education of UK Healthcare Professionals via its infield Medical Science Liaisons team, and Althea Concierge, a free online platform that provides doctors with all the education and support tools they require to prescribe CBPMs.

In addition to its existing distribution network in the UK, including multiple medical cannabis clinics, Grow Pharma offers a direct-to-patient home delivery of prescriptions at no additional cost.

For comments and feedback contact: editorial@rttnews.com

Health News

Follow RTT